Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A01 and IC01 Combination in Advanced Gastrointestinal Cancer
NCT03474861Phase 1Unknown
- Sponsor
- Hangzhou ConVerd Co., Ltd.
- Start
- Apr 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules, Cell Therapies
01
Overview
Phase 1, open-label, single-arm trial of A01 and IC01 in gastrointestinal cancer, sponsored by Hangzhou ConVerd Co., Ltd. Primary endpoint: Adverse events associated with infusion. Status: unknown.
02
Drugs
A01IC01
03
Conditions
gastrointestinal cancer
Beyond the preview
Go deeper on NCT03474861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03474861.